Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The Universitas Indonesia Faculty of Medicine (FMUI) and the University of Oxford's Eijkman Oxford Clinical Research Unit (EOCRU, embedded with the Eijkman Institute of Molecular Biology, EIMB, and part of the Vietnam/Asia Wellcome research programme) have completed a facility dedicated to the support of the many collaborative clinical research activities between the two universities.

EOCRU IOCRL (Universities of Indonesia and Oxford Clinical Research Laboratory) team, with Kevin Baird and Guy Thwaites

Hosted by the Department of Parasitology on the FMUI campus in central Jakarta, the Universities of Indonesia and Oxford Clinical Research Laboratory (IOCRL) provides an integrated medium for broader engagement with all of our Indonesian friends and partners in training, education, public engagement, and development of a broader collaborative clinical research agenda in the coming years. The IOCRL facility will be managing three active clinical trials in the coming year:

  • ACT-HIV, assessment of adjunctive dexamethasone therapy for TB meningitis in HIV-infected patients at Cipto Mangungkusomo and Persehabatan Hospitals in Jakarta (Wellcome);
  • INSPECTOR pivotal clinical trial of tafenoquine combined with an artemisinin combination therapy for radical cure of vivax malaria in Indonesian soldiers in East Java (GSK UK, Medicines for Malaria Venture, Geneva, and the Bill & Melinda Gates Foundation);
  • a randomized, double-blind, placebo-controlled trial of live Plasmodium falciparum sporozoite vaccines for prevention of acute P. falciparum and acute and latent Plasmodium vivax malaria in Indonesian soldiers (US Congressionally Directed Medical Research Program & Sanaria Inc., USA).

FMUI faculty members serve as the Principal Investigators of each of these endeavours, along FMUI, EIMB (including EOCRU), Oxford University Clinical Research Unit Viet Nam (OUCRU), and Armed Forces of Indonesia co-investigators and technical staff.

The IOCRL facility, managed by Dr Raph Hamers of Oxford University (Centre for Tropical Medicine & Global Health), serves as the administrative, regulatory, and technical hub for these complex and ambitious trials. This remarkably productive engagement of Oxford University with EIMB and FMUI approaches its tenth year with a sense of deep gratitude to these hosts for their warm Indonesian hospitality, collegiality, friendship, and professionalism.

Similar stories

Letter from the hills: The invisible burden of leprosy in Sumba

OUCRU Indonesia launches a new exhibition by photographer Yoppy Pieter based in Jakarta, Indonesia. This exhibition documents, through a series of intimate and beautiful images, the invisible burden of leprosy and other skin diseases in Sumba, an island in Nusa Tenggara Timor province, Indonesia.

Combating Antimicrobial Resistance

November 18 – 24 is World Antimicrobial Awareness Week. Antimicrobial resistance has been a key focus in OUCRU’s research for many years. Our objective is to understand and improve antimicrobial use and antimicrobial resistance in agriculture, the community, and hospitals. Our approach is interdisciplinary – led by a number of OUCRU’s research groups and public engagement teams.

OUCRU Engagement around mental health

OUCRU’s Public and Community Engagement team develops training and resources on the topic of stress management and communication skills. Run by the Public and Community Engagement team, the Youth Ambassadors programme also links young people to medical research that impacts their lives and connects researchers to the health issues that young people care about.

Abhilasha Karkey, new OUCRU Nepal Director

OUCRU Nepal is pleased to announce that as of 01 October 2022, Dr Abhilasha Karkey will assume the role of Director.

OUCRU presents a new virtual exhibition: Digital Diaries, Voices from the Pandemic, COVID-19 experiences in Asia

This online exhibition showcases short films and photographs created by health-care workers and community members and documents the socio-cultural impact of the COVID-19 pandemic in Indonesia, Nepal and Vietnam.

World Hepatitis Day: OUCRU research seeks to lower cost of treatment and improve access to care for patients with hepatitis C

Today is World Hepatitis Day. OUCRU and hospitals in Ho Chi Minh City and Hanoi have been collaborating on hepatitis C clinical trials since 2018. Our research is centred around predictive factors for selecting persons who could be successfully treated with shorter durations of antiviral therapy. OUCRU’s social science and public engagement teams are currently working with underrepresented groups to create community-led strategies to link care and treatment for populations at risk for viral hepatitis. Our aim is to have a more significant impact on the treatment strategy and access to care for patients with hepatitis C in Vietnam and worldwide in the future.